Venous thromboembolism in pregnancy & puerperium — DVT and thromboprophylaxis
Bedside summary
Pregnancy and the 6 weeks postpartum carry a several-fold increased VTE risk (venous stasis, hypercoagulability, left-sided iliofemoral DVT predominance). Have a low threshold to investigate and to start treatment-dose low-molecular-weight heparin (LMWH) while awaiting imaging. D-dimer is unreliable in pregnancy and should not be used to exclude VTE. LMWH is the anticoagulant of choice (does not cross the placenta); DOACs and warfarin are generally avoided antenatally. Thromboprophylaxis is prescribed by a risk-score at booking, antenatally and postnatally (RCOG Green-top 37a). This entry complements the existing 'Pulmonary embolism in pregnancy' protocol.
Red flags
- Signs of PE: breathlessness, pleuritic chest pain, tachycardia, hypoxia, collapse (massive PE — resuscitate, see PE entry)
- Phlegmasia cerulea dolens (massively swollen, dusky, painful leg — limb-threatening iliofemoral DVT)
- Neurological signs (CVST), severe headache
- Major bleeding on anticoagulation
- Heparin-induced thrombocytopenia (falling platelets ~day 5-10)
Assessment
Differential diagnosis
- Deep vein thrombosis (usually left leg, iliofemoral)
- Pulmonary embolism (see separate entry)
- Ruptured Baker's cyst, cellulitis, muscle tear (leg swelling)
- Superficial thrombophlebitis
- Lymphoedema / dependent oedema of pregnancy
- Ovarian vein / pelvic vein thrombosis (postpartum)
- Cerebral venous sinus thrombosis (if neurological)
Investigations
- Compression duplex ultrasound of the leg for suspected DVT (repeat in 3-7 days if negative but high clinical suspicion; consider iliac vein imaging/MRI for pelvic DVT)
- Do NOT use D-dimer to exclude VTE in pregnancy (physiologically raised)
- Baseline FBC, U&E, LFT, coagulation before starting anticoagulation; booking weight (for dosing)
- For suspected PE: ECG, CXR, then V/Q or CTPA (see PE-in-pregnancy entry)
- Thrombophilia testing is generally NOT done acutely (affected by pregnancy/clot/heparin) — defer
- Assess bleeding risk, renal function (dose adjust LMWH if eGFR low)
Management
- If VTE clinically suspected, start treatment-dose LMWH immediately unless contraindicated, while arranging imaging (do not wait for the scan)
- Confirm with compression duplex (DVT) or CTPA/VQ (PE); if imaging negative but suspicion high, repeat/continue per protocol
- Dose LMWH by early-pregnancy/booking weight; treat as twice-daily or once-daily regimen per local policy; monitor anti-Xa only at extremes of weight/renal impairment
- Continue therapeutic LMWH for the rest of pregnancy and at least 6 weeks postpartum (minimum 3 months total treatment)
- Plan peripartum anticoagulation: omit LMWH at onset of labour/planned 24 h before induction or caesarean; neuraxial anaesthesia timing per last dose (e.g. >= 24 h after therapeutic dose)
- Postnatal: can switch to warfarin or (if not breastfeeding-restricted) LMWH; DOACs generally avoided in breastfeeding [verify local]
- For prophylaxis: apply RCOG risk assessment at booking, on admission, and postnatally; prescribe weight-banded prophylactic LMWH to those meeting thresholds (e.g. after caesarean, immobility, obesity, prior VTE, thrombophilia)
- Fit graduated compression stockings; encourage mobility/hydration
- Provide written information; arrange maternal-medicine/haematology follow-up
Drugs & doses
Disposition
Complications & pitfalls
- Pulmonary embolism (potentially fatal)
- Post-thrombotic syndrome, chronic venous insufficiency
- Recurrent VTE; pregnancy-associated clot propagation
- Bleeding from anticoagulation; HIT (rare with LMWH)
- Heparin-induced osteoporosis (long-term use)
Exam pearls
- D-dimer does not exclude VTE in pregnancy — image instead.
- Pregnancy DVT is usually left-sided and iliofemoral; consider pelvic vein imaging if calf scan is negative but suspicion high.
- Start treatment-dose LMWH on clinical suspicion before the scan; do not wait.
- LMWH is the anticoagulant of choice; warfarin is teratogenic and DOACs are avoided in pregnancy/breastfeeding.
- Continue anticoagulation for the whole pregnancy and at least 6 weeks postpartum (minimum 3 months total).
- Do a documented RCOG VTE risk assessment at booking, on any admission, and postnatally — most maternal PE deaths follow missed prophylaxis.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.